Psychemedics Q3 revenue up 29% to $6.7M; net income $0.13 EPS vs loss of $0.20

PSYCHEMEDICS CORP

2021-Q3 EPS reported $0.17 revenue$18,473,000

Revenue $6.7M vs $5.2M YoY (+29%); domestic revenue up 27% YoY.
Net income of $0.7M ($0.13 diluted EPS) vs net loss of $1.1M (-$0.20).
Employee Retention Credit of $0.8M reduced costs; dividend remains suspended.
Exploration of strategic alternatives continues with JMP Securities; no timetable.
PPP loan of $2.2M fully forgiven by SBA in July 2021.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.